Met Life Investment Management, LLC Celldex Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 39,620 shares of CLDX stock, worth $889,865. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,620
Previous 37,332
6.13%
Holding current value
$889,865
Previous $1.27 Million
21.06%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$202 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$114 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$87.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$84.3 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.05B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...